V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10008763 | 10004040 | 1.7 | 70 | Disease modification (D) | 2018-07-06 | 2019-07-30 | Rituximab | null | null | 10372946 | RITUXIMAB |
| 10008764 | 10004064 | 1.75 | null | Palliative (P) | 2018-07-15 | 2018-07-22 | TRASTUZUMAB | N | N | 10376164 | TRASTUZUMAB |
| 10008765 | 10004070 | 1.58 | 62.2 | Curative (C) | 2018-01-18 | 2018-05-12 | CHOP R | 02 | N | 10377105 | CHOP R |
| 10008766 | 10004077 | 1.72 | 63 | Palliative (P) | 2018-03-03 | 2018-03-23 | Trastuzumab Subcutaneous | 2 | N | 10377488 | TRASTUZUMAB |
| 10008767 | 10004084 | 1.66 | 75 | Palliative (P) | 2019-09-26 | 2019-12-30 | Rituximab | 99 | N | 10378293 | RITUXIMAB |
| 10008768 | 10004087 | 1.88 | 45.5 | Palliative (P) | 2019-02-12 | 2019-04-05 | PEMBROLIZUMAB | null | null | 10378970 | PEMBROLIZUMAB |
| 10008769 | 10004092 | 1.68 | 83 | Disease modification (D) | 2018-01-12 | 2018-01-30 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 10379515 | RITUXIMAB |
| 10008770 | 10004095 | 1.77 | null | Curative (C) | 2016-01-15 | 2016-03-06 | Capecitabine + Oxaliplatin 14day | 02 | N | 10379596 | CAPECITABINE + OXALIPLATIN |
| 10008771 | 10004103 | 1.83 | 73.45 | null | 2017-12-17 | 2018-03-01 | Trastuzumab Subcutaneous | N | N | 10380124 | TRASTUZUMAB |
| 10008772 | 10004106 | 1.7 | 74.2 | Palliative (P) | 2014-09-18 | 2015-03-08 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 10380133 | RITUXIMAB |
| 10008773 | 10004110 | 1.55 | 57.9 | Curative (C) | 2017-12-05 | 2017-12-13 | PEMBROLIZUMAB | N | N | 10380173 | PEMBROLIZUMAB |
| 10008774 | 10004113 | 1.85 | 96.7 | Adjuvant (A) | 2015-05-14 | 2015-05-23 | PACLITAXEL | 02 | N | 10380355 | PACLITAXEL |
| 10008775 | 10004115 | 1.78 | null | Palliative (P) | 2016-03-15 | 2017-06-01 | Oxaliplatin + Modified de Gramont | 02 | N | 10380457 | OXALIPLATIN + MDG |
| 10008776 | 10004118 | 1.83 | 80.3 | Disease modification (D) | 2016-12-28 | 2017-01-12 | Docetaxel | N | N | 10380618 | DOCETAXEL |
| 10008777 | 10009246 | null | 66.3 | Palliative (P) | null | 2019-01-03 | Trastuzumab 21 day maintenance | 1 | 2 | 10382154 | TRASTUZUMAB |
| 10008778 | 10004127 | 1.82 | 65.8 | Neo-adjuvant (N) | 2016-10-01 | 2016-10-01 | TRASTUZUMAB | 2 | N | 10382324 | TRASTUZUMAB |
| 10008779 | 10004141 | 1.8 | 121.7 | Palliative (P) | 2014-09-19 | 2014-09-20 | CHOP R - 21 days | N | null | 10385370 | CHOP R |
| 10008780 | 10004143 | 1.68 | 92.3 | Palliative (P) | 2019-04-17 | 2019-04-17 | Rituximab (Maintenance) | N | N | 10385413 | RITUXIMAB |
| 10008781 | 10004151 | 1.7 | 84.6 | Palliative (P) | 2019-03-09 | 2019-03-09 | Rituximab | 2 | N | 10386677 | RITUXIMAB |
| 10008782 | 10004156 | 1.57 | 73.7 | Palliative (P) | 2018-06-02 | 2018-06-05 | Oxaliplatin + Modified de Gramont | N | N | 10408810 | OXALIPLATIN + MDG |
| 10008783 | 10004158 | 1.62 | 52.7 | Disease modification (D) | 2016-08-19 | 2016-08-24 | Oxaliplatin + Modified de Gramont | N | N | 10409013 | OXALIPLATIN + MDG |
| 10008784 | 10004162 | 1.6 | 96.8 | Disease modification (D) | 2017-11-28 | 2017-12-14 | Docetaxel | N | null | 10409174 | DOCETAXEL |
| 10008785 | 10004167 | 1.59 | 50.5 | Palliative (P) | 2016-04-04 | 2016-08-10 | Capecitabine | 1 | N | 10409858 | CAPECITABINE |
| 10008786 | 10004169 | 1.7 | 91.5 | Palliative (P) | 2017-10-02 | 2017-10-02 | Capecitabine | 02 | null | 10410097 | CAPECITABINE |
| 10008787 | 10004174 | 1.82 | 120 | Palliative (P) | 2015-09-17 | 2015-10-04 | FLUOROURACIL | N | N | 10410582 | IBRUTINIB |
| 10008788 | 10004176 | 1.61 | 63.1 | Palliative (P) | 2017-12-17 | 2017-12-17 | IBRUTINIB | N | N | 10410849 | FLUOROURACIL |
| 10008789 | 10004185 | 1.72 | 60 | Palliative (P) | 2017-12-30 | 2018-02-17 | Bevacizumab 7.5mg/kg | 02 | null | 10411715 | NOT MATCHED |
| 10008790 | 10004188 | 1.52 | 59.8 | Palliative (P) | 2016-09-26 | 2017-01-15 | CARBOPLATIN + VINORELBINE | N | N | 10411839 | CARBOPLATIN + PEMETREXED |
| 10008791 | 10004191 | 1.53 | 63.2 | Palliative (P) | 2018-06-03 | 2018-06-03 | IBRUTINIB | 02 | N | 10412008 | GEMCITABINE |
| 10008792 | 10004214 | 1.73 | 45 | Palliative (P) | 2015-02-27 | 2015-08-09 | Bevacizumab | N | N | 10415459 | NOT MATCHED |
| 10008793 | 10007203 | 1.68 | 81.4 | Palliative (P) | 2017-09-20 | 2017-10-25 | Capecitabine | N | N | 10416337 | CAPECITABINE |
| 10008794 | 10004222 | 1.61 | 77.6 | Palliative (P) | 2018-06-15 | 2018-09-04 | Pemetrexed | N | N | 10416667 | IBRUTINIB |
| 10008795 | 10004224 | 1.8 | null | Palliative (P) | 2018-07-17 | 2019-04-25 | Bevacizumab | 2 | N | 10416814 | BEVACIZUMAB |
| 10008796 | 10004227 | 1.95 | null | Neo-adjuvant (N) | 2014-01-09 | 2014-05-27 | Bevacizumab | N | N | 10417018 | PEMETREXED |
| 10008797 | 10004232 | 1.79 | 83.2 | Palliative (P) | 2018-04-03 | 2018-04-03 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10419141 | NOT MATCHED |
| 10008798 | 10004234 | 1.62 | null | Adjuvant (A) | 2016-07-11 | 2016-07-11 | Trial Unspecified | N | N | 10420074 | TRIAL |
| 10008799 | 10004238 | 1.73 | null | Palliative (P) | 2018-12-20 | 2018-12-20 | BENDAMUSTINE + RITUXIMAB | N | N | 10426874 | BENDAMUSTINE + RITUXIMAB |
| 10008800 | 10004241 | 1.9 | null | Palliative (P) | 2016-12-31 | 2017-09-05 | Bendamustine+Rituximab(Sub Courses) | N | N | 10427051 | BENDAMUSTINE + RITUXIMAB |
| 10008801 | 10004244 | 0 | 85 | Palliative (P) | 2018-04-09 | 2018-11-22 | GEMCARBO | 02 | N | 10427387 | CARBOPLATIN + PEMETREXED |
| 10008802 | 10004250 | 0 | 62.8 | Palliative (P) | 2019-07-06 | 2019-07-20 | Capecitabine | 2 | N | 10427534 | CAPECITABINE |
| 10008803 | 10007218 | 1.64 | 70 | Palliative (P) | 2017-01-19 | 2017-01-19 | BENDAMUSTINE + RITUXIMAB | N | N | 10427636 | BENDAMUSTINE + RITUXIMAB |
| 10008804 | 10004254 | 1.82 | 77 | Disease modification (D) | 2016-03-16 | 2016-03-17 | null | N | N | 10427643 | CARBOPLATIN + PEMETREXED |
| 10008805 | 10004258 | 1.71 | 83.8 | Palliative (P) | 2017-11-13 | 2017-11-13 | BENDAMUSTINE + RITUXIMAB | N | N | 10427777 | BENDAMUSTINE + RITUXIMAB |
| 10008806 | 10004259 | 1.83 | 71 | Palliative (P) | 2017-03-06 | 2019-03-31 | Trial Unspecified | 02 | N | 10428137 | TRIAL |
| 10008807 | 10004271 | 1.83 | 73 | Palliative (P) | 2017-09-07 | 2017-09-08 | BCG Intravesical | 2 | N | 10428954 | PEMETREXED |
| 10008808 | 10004281 | 1.74 | 77.1 | Palliative (P) | 2016-02-02 | 2016-09-08 | Carboplatin + Etoposide iv&po | N | N | 10429495 | CARBOPLATIN + ETOPOSIDE |
| 10008809 | 10007232 | null | 67.9 | Palliative (P) | 2016-05-15 | 2017-04-07 | Trial Unspecified | N | N | 10430016 | TRIAL |
| 10008810 | 10004295 | 1.71 | 75 | Palliative (P) | 2018-11-28 | 2019-04-18 | Pemetrexed | 2 | null | 10430403 | ABIRATERONE |
| 10008811 | 10004297 | null | 60 | Palliative (P) | 2013-02-12 | 2017-04-01 | Carboplatin + Etoposide iv&po | null | null | 10430585 | CARBOPLATIN + ETOPOSIDE |
| 10008812 | 10004303 | 1.83 | 86 | Palliative (P) | null | 2019-02-15 | Pemetrexed | 02 | N | 10430787 | CARBOPLATIN + PEMETREXED |